Acute phase reactants in patients with RA cause synovitis, and elevated levels of inflammatory cytokines such as tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) induce atherosclerotic changes and endothelial function damage, leading to an increased risk of MI (29). This evidence concerns the gene IL6 and rheumatoid arthritis.